ReviewCurrent treatment options in oncology2023

Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice.

Fausto Alfredo Rios-Olais et al.PubMed ↗Publisher ↗

No numbers read from the abstract.